Abstract Ciprofloxacin was incorporated to plain bioresorbable self-reinforced polylactide/glycolyde 80/20 screws and tacks (ciprofloxacin releasing SR-PLGA). These implants were compared to otherwise similar conventional fixation devices. The effect of the ciprofloxacin addition on the pull-out force of screws and tacks was evaluated in human cadaver cranial bones. SR-PLGA tacks applied to cranial bone with a special applicator gun had a similar holding power as screws. Addition of the antibiotic compromised the strength of the screws so that ciprofloxacin-containing PLGA screws had lower pull-out strength than corresponding plain PLGA screws. Scanning electron microscopy showed that the fibrillar strip-like microstructure of plain SR-PLGA screws turned into a coarse uni-axial platelet-like pattern as a result of ciprofloxacin addition. It is concluded that this type of 4 mm long and 1.5 mm diameter ciprofloxacin-containing screws can only be used in non-load-bearing or slightly load-bearing applications. Tissue reactions elicited by plain bioresorbable self-reinforced polylactide/glycolide (SR-PLGA) 80/20 screws were compared to similar but ciprofloxacin-releasing SR-PLGA fixation devices in rabbit cranial bone. Plain and ciprofloxacin-PLGA 80/20 screws elicited only mild inflammatory reactions upon implantation in rabbit cranial bone, but they did not interfere with osteoblast activity in up to 72 week long follow-up. Release of the antibiotic from ciprofloxacin-PLGA screws was gradual and the drug concentration in bone tissues was still higher at 8 weeks than the minimal inhibitory concentration (MIC) of ciprofloxacin for S. aureus (0.1–1.0 μg/g). Ciprofloxacin-releasing SR-PLGA screws can find clinical usage in the prevention of implant-related infections in osteofixation in craniomaxillofacial bones in non-load-bearing or slightly load-bearing applications. Larger 6 mm long and 2 mm diameter ciprofloxacin-releasing tacks had a similar holding power to cranial bone as conventional tacks. Tacks can be recommended for clinical use as the application procedure saves time and costs.

This dissertation is focused on the controlled release of drugs from a biodegradable amphiphilic hydrogel based on hydrophobic poly(lactic acid), poly(glycolic acid) and hydrophilic poly(ethylene glycol) (PLGA-PEG-PLGA, ABA) and its modification with itaconic anhydride (ITA). The resulting ,-itaconyl(PLGA-PEG-PLGA) copolymer is referred to as ITA/PLGA-PEG-PLGA/ITA or ITA/ABA/ITA. Itaconic acid provides reactive double bonds and a functional carboxyl group at the ends of the PLGA-PEG-PLGA copolymer chain, thereby rendering the modified ITA/ABA/ITA copolymer less hydrophobic and offering the possibility of forming a carrier for hydrophilic drug substances. These functional copolymers are thermosensitive and change in the external environment (e.g. temperature) causes a sol-gel phase transition due to the formation of micellar structure. The bioactive substances can thus be mixed with a copolymer which is in a low viscous phase (sol phase) and subsequently the mixture can be injected into patient's body at the target site where it forms a gel at 37 °C. This hydrogel becomes a drug depot, which gradually releases the active substance. Prediction of the substance’s release profile from the hydrogel is an effective tool to determine the frequency of administration, potentially enhancing efficacy, and assessment of side effects associated with dosing. The analgesic paracetamol and the sulfonamide antibiotic sulfathiazole were used as model drugs, representing hydrophilic and hydrophobic substances, respectively. The active substances had a significant effect on the resulting hydrogel stiffness. Type of solvent, incubation medium and nanohydroxyapatite also influenced on the gel stiffness and subsequent stability of the hydrogel-drug system. Controlled release of drugs took place in simulated conditions of the human body. Verification of Korsmeyer-Peppas (KP) drug-release model is also discussed in this thesis. The KP model was found suitable for simulating the release of sulfathiazole from ABA and ITA/ABA/ITA hydrogels. On the contrary, the performance of KP model was not suitable for describing the release of paracetamol from the ABA hydrogels. Therefore, a new regression model suitable for both buffered simulated media and water has been proposed. The proposed model fitted better the release of both sulfathiazole and paracetamol from composite material prepared from ABA hydrogel and nanohydroxyapatite.

10 ABSTRACT Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Technology Consultant: PharmDr. Ondřej Holas, PhD. Student: Jiřina Blažková Title of thesis: A study of biodegradable polyesters based nanoparticles properties Nanoparticles (NPs) are particles with a diameter size ranging between 1 - 500 nm. They are preferably used as drug delivery systems or imaging systems. NPs are able to encapsulate both hydrophilic and hydrophobic drugs and also macromolecules such as peptides or mRNAs. The aim of this study was to specify selected properties of NPs prepared from poly (lactide-co-glycolide) polymer (PLGA) using polyvinyl alcohol as a surfactant. Nanoprecipitation was chosen as a preparation method. NPs were prepared from a branched PLGA copolymer and from a conventional linear PLGA polymer/oligomer. The main task was a stability study. The effect of the pH and the type of the used polymer of the nanoparticle suspension on the morphology of the nanoparticles was evaluated over one month period. The following parameters of nanoparticles with two model drugs (curcumin and procaine) were also monitored: encapsulation efficiency, drug loading and recovery yield. Dissolution tests were performer and the suitability of individual polymers for different types of drugs...

Spinal cord injury (SCI) leads to axonal damage and limits the ability of the brain to communicate with the rest of the body. Several bioengineered approaches have been developed for the recovery of SCI. Among these techniques, degradable guidance tubes have shown promising results. However, design of nerve guide tubes requires several design considerations and has been a significant challenge. To assess the efficacy of a prototypical implanted nerve guide tubes, it is essential to perform continuous monitoring. In this respect, magnetic resonance imaging (MRI) is one of the most reliable imaging techniques as it offers the ability to achieve extraordinary high temporal and spatial resolution in addition to its non-invasive features. In spite of the excellent image quality of non-enhanced MRI various types of contrast agents have been developed to further enhance the contrast and allow improved visualization. The MRI contrast agents principally work by shortening the T1 or T2 relaxation times of protons located nearby. The presented study was intended to evaluate the in vitro degradation of the nerve guide tubes made of poly (lactic-co-glycolic acid) (PLGA). PLGA tubes incorporated with different concentrations of superparamagnetic iron oxide (SPIO) were scanned by MRI 3T on weekly basis during the degradation period. Spin-echo (SE) sequence with various echo times (TEs) ranged from 13.3 to 314.4 msec was applied. T2 mapping was computed using in-house algorithm developed in Matlab. Least square fit was used to find the slope of the decay curve by plotting log intensity on the y-axis and echo time on the x-axis. The average T2 values were calculated. Mass loss and water uptake of the degrading tubes were also measured weekly. Moreover, the micro-structural changes of the tubes were investigated using the scanning electron microscope (SEM). The MRI results showed that the concentration of SPIO affects the signal intensity of the T2 weighted images reducing the T2 relaxation time value. Accordingly, a linear correlation between SPIO concentration and T2 relaxation time was found. At the beginning of degradation, the SPIO nanoparticles were trapped within the polymeric network. Therefore, water penetration was the predominant factor affecting the T2 relaxation times. At week 5, a significant mass loss was observed. From this stage onwards, the trapped SPIO were released from the polymeric network increasing T2 relaxation time dramatically. According to SEM images, the size of the pores in PLGA guide tubes was increased with the degradation. Approaching the end of degradation, shrinkage of the tubes was observed and the degraded nerve guide tubes were shown to be collapsed. Similar shape variation was observed in T2 weighted MR images. In summary, this study provided an approach to non-invasive monitoring of degradation behavior of nerve guide tubes using contrast enhancement. The developed technique is of great importance since it opened an insight to non-invasive monitoring of tissue engineered scaffolds for in vivo studies.

No description available.

No description available.

Les nucléotides naturels et les analogues nucléotidiques présentent des activités pharmacologiques importantes : par exemple, le nucléotide adénosine triphosphate (ATP) présente un intérêt pour le traitement de l'ischémie ou de plaques d'athérosclérose. L'utilisation clinique de ces molécules est cependant limitée en raison de la présence d'un groupe triphosphate, qui est sujet à l'hydrolyse in vivo, et responsable de la forte hydrophilie des molécules, ce qui limite fortement leur capture par les cellules cibles et l'accès à leurs cibles pharmacologiques intracellulaires. Pour surmonter ces limitations et permettre l'administration de nucléotides et d’analogues nucléotidiques, l'utilisation de systèmes de drug delivery comme les nanoparticules pourrait assurer la protection et l'administration ciblée des molécules actives. Cependant, les nanoparticules conçues pour l’administration intraveineuse ne sont pas toujours adaptées au traitement de certaines maladies chroniques. C’est pour cela qu’un implant sous-cutané avec des caractéristiques de libération prolongée peut représenter une alternative valable, tout en étant peu invasif et capable d’atteindre les tissus lymphatiques, cible importante de plusieurs thérapies.Le premier chapitre de cette thèse porte sur la formulation de nanoparticules pour encapsuler l’ATP ou la zidovudine triphosphate (AZT-TP), grâce à la présence du chitosane (CS). Ces nanoparticules sont formées par interactions ioniques entre les charges positives du chitosane et les charges négatives des groupes triphosphates de l’ATP ou de l’AZT-TP. Dans ce travail, les nanoparticules sont caractérisées et leur délivrance cellulaire de l’ATP et de l’AZT-TP est démontrée sur une lignée cellulaire de macrophages. Dans un deuxième temps, la stabilité de ces systèmes a été améliorée afin d'obtenir un meilleur comportement en conditions physiologiques. Cette amélioration de la stabilité a été obtenue par la complexation du fer(III) au chitosane (CS-Fe). Cette stratégie a été appliquée aux nanoparticules de tripolyphosphate (TPP) et d’ATP. Les nanoparticules ont été ensuite testées sur deux lignées de cellules macrophagiques, montrant une internalisation améliorée de l’ATP par rapport aux nanoparticules précédentes. Enfin, les nanoparticules à base de CS-Fe et ATP ont été dispersées dans une solution de PLGA, dans le but de mettre au point un implant à formation in situ. Une fois en contact avec les fluides physiologiques, la suspension prend la forme d’un dépôt solide. Des études de libération in vitro montrent la capacité des systèmes de retenir les nanoparticules à l’intérieur de la matrice et de les libérer de façon progressive pendant 5 jours. Après administration sous-cutanée chez la souris, les implants de PLGA contenant les nanoparticules ont retenu l’ATP au lieu de l’injection jusqu’à 50 heures, comparé à quelques heures pour l’ATP libre et les nanoparticules libres, montrant ainsi leur pertinence comme systèmes pour la libération prolongée de nucléotides. / Natural nucleotides and nucleotide analogs display important pharmacological activities: for example the nucleotide adenosine triphosphate (ATP) could be an interesting molecule for the treatment of ischemia or atherosclerotic plaques. The clinical use of these molecules is however limited due to the presence of a triphosphate group, which is prone to hydrolysis in vivo, and responsible for the high hydrophilicity of the molecules, thereby strongly limiting their uptake by targeted cells and access to their intracellular pharmacological targets. To overcome these limitations and enable the administration of nucleotides and nucleotide analogs, the use of drug delivery systems such as nanoparticles may enable the protection and the targeted delivery of these drugs. Nanoparticles designed for intravenous injections are however not always convenient, e.g. in the case of chronic diseases. Therefore, a subcutaneous implant with sustained release features might represent a valid alternative, which is less invasive and can reach lymphatic tissues (important targets of many therapies). The first chapter of this thesis presents the formulation of nanoparticles to encapsulate ATP as well as zidovudine triphosphate (AZT-TP), thanks to the presence of chitosan (CS). These nanoparticles are formed through ionic interactions between the positive charges of chitosan and the negative charges of the triphosphate groups of ATP or AZT-TP. In this work, nanoparticles are characterized and their cellular delivery of ATP and AZT-TP inside a macrophage cell line is demonstrated. In a second time, the stability of these systems has been improved in order to obtain a better behavior in physiological conditions. This improved stability has been achieved through the complexation of chitosan to iron(III) (CS-Fe). This strategy has been applied to TPP and ATP nanoparticles. These nanoparticles have been tested on two macrophages cell lines showing an improved internalization compared to the previous ones. Finally, CS-Fe/ATP nanoparticles have been dispersed in a PLGA solution in order to develop an in situ forming implant. Once in contact with physiological fluids, the suspension turns into a solid depot. In vitro release studies show the ability of the systems to retain nanoparticles inside the matrix and to gradually release them over 5 days. After subcutaneous administration to mice, PLGA implants containing nanoparticles were able to retain ATP at the injection site for up to 50 hours, as compared to few hours of free ATP or free nanoparticles, showing therefore their relevance as sustained release systems of nucleotides.

Apesar do desenvolvimento da tecnologia envolvendo o campo da regeneração em nervos periféricos, ainda não existe uma técnica para recuperação do tecido nervoso que apresente resultados totalmente satisfatórios, fato que desperta o interesse de vários pesquisadores em todo mundo e representa um desafio para os cirurgiões que realizam procedimentos reconstrutivos e estéticos. Embora o enxerto autólogo de nervo seja a melhor alternativa para a recuperação de nervos periféricos lesados, as técnicas que envolvem o reparo tubular têm alcançado excelentes resultados através da utilização de materiais sintéticos e biológicos, sob a forma de tubos, no reparo de extensos segmentos nervosos. Hoje, através dos avanços da engenharia tecidual, novos materiais estão em desenvolvimento, com o objetivo de aliar características microscópicas às técnicas cirúrgicas existentes. O colágeno, que é sabidamente um elemento promotor da proliferação celular e do reparo tecidual, tem sido amplamente utilizado em estudos de regeneração nervosa. Da mesma maneira, o ácido poli-láctico-poli-glicólico (PLGA), um copolímero sintético, tem apresentado algumas características favoráveis ao processo de regeneração, como biocompatibilidade e propriedades mecânicas adequadas. Com o propósito de facilitar a regeneração nervosa quando ocorre perda tecidual, uma técnica já difundida pode ser destacada: o enxerto de veia invertida, em que a veia jugular externa é utilizada ao avesso, funcionando como um tubo, criando um microambiente para a regeneração nervosa, através da exposição de elementos fundamentais da camada mais externa do vaso (túnica adventícia). Neste trabalho, agregamos como diferencial a utilização de dois tipos de membranas, especialmente desenvolvidas para fins odontológicos, que visam neoformação óssea, em um estudo que visa à regeneração de um nervo periférico misto, o nervo isquiático. As membranas de colágeno e PLGA foram colocadas na região do enxerto, sob a forma de tubo, com o objetivo de recuperar um segmento de 10 mm do nervo referido. E, por fim, aliamos a utilização de um segmento de 5 mm da veia jugular externa como tecido de preenchimento dos tubos feitos com as membranas, na tentativa de verificar a eficácia das moléculas biológicas presentes neste vaso, porém agora sendo utilizadas diretamente dentro do enxerto. Após um período de 6 semanas, o grupo que apresentou o melhor resultado foi aquele em que foi utilizada a membrana de colágeno, na forma de tubo, preenchida com a veia jugular externa. Nesse grupo, o diâmetro médio das fibras mielínicas apresentou um valor médio de 5,8 µm e espessura média da bainha de mielina de 1,65 µm. Para o período de 12 semanas, entre os grupos analisados, o maior valor médio encontrado para o diâmetro foi de 5,64 µm e 1,31 µm para a espessura, sendo que este resultado foi apresentado pelo grupo em que se utilizou a membrana de PLGA sem preenchimento com a veia jugular. Embora os valores não sejam muito inferiores, nos dois períodos, ficaram abaixo dos valores encontrados nos grupos controle normais. Em suma, acreditamos que as membranas de colágeno e PLGA, associadas à técnica de tubulização, apresentam grande potencial para serem utilizadas na regeneração de nervos periféricos. / Despite the development of technology involved in peripheral nerve regeneration, there is no technique that presents a recovery of the nervous tissue with completely satisfactory results. This fact arouses interest of several researchers around the word. Although the autologous nerve grafting is the current gold standard for the repair of large nerve gaps, over the past decades the development of artificial nerve conduits has therefore been of great interest due to the excellent results achieved. Through the advances in tissue engineering, new materials, synthetic and biological, have been used for construct nerve guides. The collagen is one of the oldest natural polymers used as a biomaterial, and it is known as a promoter of cell proliferation and of tissue repair. In the same way, the synthetic copolymer, poly lactic-co-glycolic acid (PLGA), have been used for nerve regeneration, and it have shown some favorable characteristics to nerve repair such as stability, biocompatibility, and mechanical properties. With the purpose of facilitating the regeneration in large nerve gaps, the inside-out vein graft is a widespread technique, where the vein works as a conduit, and it provides a good microenvironment for axon regeneration through the exposition of some primordial elements of its adventitial layer. In this work, we join as a differential the use of two materials, specially developed for dental purposes, which are normally used to facilitate the osteogenesis, in a nerve regeneration study. We performed the surgical procedures in the sciatic nerve, with two types of membranes (PLGA and collagen), which were used as tubes, in order to promote the regeneration of this nerve. The collagen and PLGA membranes were used with the objective of a recovery in a 10-mm sciatic nerve gap model. These tubular implants were filled with a 5 mm segment of the jugular vein in order to verify the effectiveness of some biological molecules of the adventitia layer in the nerve regeneration. After 6 and 12 weeks the graft and the distal stump were observed under light microscopy. In each studied period, the diameters of the myelin fibers, and the thickness of the myelin sheaths of the regenerated axons were measured. After 6 weeks, the group which presented the best result was the group with the collagen membrane tube filled with the external jugular vein. In this group the diameter of the myelin fibers presented an average value of 5.8 µm and an average value of the thickness of the myelin sheaths of 1.65 µm. After 12 weeks, between all the groups, the best results were found in the group where the PLGA membrane unfilled with the external jugular vein was used as a nerve guide, which presented the average diameter of 5.64 µm, and the average thickness of 1.31 µm. Although the average values werent much lower than the values found in the controls, they were beneath than the normal groups. These results proved that the collagen and the PLGA membranes have a great potential to be used as artificial nerve conduits for promoting peripheral nerve regeneration.

Tem sido sugerido que um adequado reparo ósseo pode ser obtido por biomateriais híbridos, produzidos pela combinação de células e materiais substitutos ósseos macroporosos. O objetivo geral do presente estudo foi avaliar a aplicação do biomaterial híbrido formado pelo arcabouço de PLGA/CaP e células-tronco mesenquimais e osteoblastos derivados de medula óssea na engenharia de tecido ósseo. Para verificar qual o tamanho de poro deste arcabouço é mais adequado para este fim, foram realizados experimentos in vitro, que avaliaram a proliferação celular, atividade de fosfatase alcalina (ALP) e expressão quantitativa de genes marcadores do fenótipo osteoblástico em células cultivadas sobre os arcabouços; e in vivo, que avaliaram a formação óssea após implantação do arcabouço em defeitos ósseos críticos de calvária de ratos. Também foi avaliado o efeito do tamanho dos poros sobre o carreamento celular através da força centrifuga. Para avaliar o efeito do soro fetal bovino, utilizado na suplementação do meio de cultura celular, na resposta tecidual in vivo, arcabouços expostos ao soro foram implantados em defeitos ósseos críticos de calvária de ratos. O efeito da retirada do soro fetal bovino do meio de cultura sobre osteoblastos foi analisado através da proliferação celular, atividade de ALP, conteúdo de proteína total e mineralização. Para avaliar o efeito do estágio de diferenciação celular sobre a formação óssea, células em diferentes estágios de diferenciação osteoblástica associadas ao arcabouço de PLGA/CaP foram implantadas de forma autóloga em defeitos ósseos críticos de calvária de ratos. Arcabouços com tamanhos de poros de aproximadamente 1000 µm promovem maior diferenciação osteoblástica e melhor carreamento celular, enquanto arcabouços com poros de aproximadamente 500 µm promovem maior formação óssea e vascular in vivo. O soro fetal bovino influenciou negativamente a resposta tecidual e a formação óssea. A retirada do soro fetal bovino do meio de cultura reduziu a proliferação celular e a atividade de ALP sem afetar o conteúdo de proteína total e a formação de matriz mineralizada. Células-tronco mesenquimais indiferenciadas e em fase inicial de diferenciação osteoblástica (7 dias) promoveram maior formação óssea, portanto permitiriam a obtenção de um biomaterial híbrido com maior potencial osteogênico. / It has been suggested that an adequate bone repair can be obtained by hybrid biomaterials, produced by combining osteoprogenitor cells and macroporous bone substitutes. The aim of this study was to evaluate the application of hybrid biomaterial formed by PLGA/CaP scaffold and bone marrow-derived mesenchymal stem cells and osteoblasts in bone tissue engineering. The effect of scaffold pore size was evaluated in vitro assessing cell growth, alkaline phosphatase (ALP) activity, and quantitative gene expression of osteoblastic phenotype markers in osteoblasts cultured on scaffolds; and in vivo assesseing bone formation after implantation of scaffolds in critical size rat calvaria defects. It was also evaluated the effect of pore size on cell seeding by centrifugal force. To evaluate the effect of fetal calf serum used to supplement the cell culture medium on in vivo tissue response, scaffolds exposed to serum were implanted in critical size rat calvaria defects. The effect of withdrawal of fetal calf serum in the culture medium on osteoblasts was analyzed by cell growth, ALP activity, total protein content and mineralization. To evaluate the effect of cell differentiation stage on bone repair, cells either undifferentiated or in different stages of osteoblast differentiation associated with the PLGA/CaP were implanted autologously in critical size rat calvaria. Scaffolds with pore sizes of around 1000 µm would favor the osteoblast differentiation and display a better cell seeding, while the scaffolds with pore sizes of around 500 µm would favor increased bone and vascular formation. The fetal calf serum influenced negatively the in vivo tissue response and bone formation. The withdrawal of fetal calf serum in the culture medium reduced cell growth and ALP activity without affecting the total protein content and the formation of mineralized matrix Mesenchymal stem cells and osteoblats at the early stage of differentiation (7 days) promoted greater bone formation, therefore they would allow the obtention of a hybrid biomaterial with higher osteogenic potential.

Apesar da existência de uma quimioterapia, a tuberculose (TB) ainda permanece como uma das principais causas de mortalidade no mundo, especialmente nos países em desenvolvimento, em grande parte devido à epidemia da AIDS. Geralmente, a atual terapia da TB é eficiente, no entanto, ela implica em um longo tratamento com efeitos colaterais não desejáveis e consequentemente com pouca adesão. Tem sido relatada uma crescente incidência de cepas de Mycobacterium tuberculosis resistentes a múltiplos fármacos, sendo que uma das maiores razões para isso é a terapia ineficaz, provavelmente devido à carência na adesão. Portanto, a busca por novos fármacos e com o desenvolvimento de uma terapia eficiente para a TB, que aumente a adesão do paciente e reduza o surgimento de cepas resistentes á múltiplos fármacos é muito importante. A microencapsulação pode ser usada de forma segura para a liberação sistêmica de fármacos e também para direcionar a ação para o sítio de infecção. Dessa forma, um análogo sintético de neolignana (ASN) que apresentou destacada aitividade in vitro contra o M. tuberculosis foi encapsulado em micropartículas de co-polímeros do ácido lático e glicólico (PLGA) para a liberação sustentada deste composto. Tipos diferentes de micropartículas de PLGA contendo este fármaco foram desenvolvidas pela técnica de evaporação de solvente e posteriormente, elas foram avaliadas. A formulação contendo o ASN que exibiu a melhor eficiência de encapsulação e também demonstrou uma liberação sustentada foi verificada em um modelo de camundongo infectado com TB. O tratamento com as formulações de micropartículas resultou em uma depuração dos bacilos comparado aos controles. Além disso, os resultados da análise de cortes histológicos sugerem que estas formulações não induzem a nenhuma hepatotoxicidade. Estes resultados demonstraram a possibilidade de se usar formulações de micropartículas contendo o ASN para a obtenção de resultados efetivos em modelos murinos de TB, e indicaram o potencial do ASN como um novo fármaco antimicobacteriano. / Despite the existence of chemotherapy, tuberculosis (TB) still remains a leading cause of mortality of worldwide, especially in the developing countries, in part due to the AIDS epidemic. Current therapy of TB is generally effective, however, it involves a long course of treatment with unwanted side effects and consequently with poor compliance. An increasing incidence of multiple-drug-resistant strains of Mycobacterium tuberculosis (MDR-TB) has been related and one of the major reasons for this is inefficient therapy, probably due to lack of compliance. Thus, it is very important to search for new drugs with a development of an effective therapy for TB that improves patient compliance and reduces the emergency of MDR-TB. Microencapsulation technology can be used to safely deliver drugs systemically and target drugs to the site of infection. In this way, a synthetic analogue of a neolignan (SAN) that had a remarkable in vitro activity against M. tuberculosis was entrapped in poly (D,L-lactide-co-glycolide) (PLGA) microparticles for sustained delivery of this compound. Different types of PLGA microparticles containing this drug were developed by the solvent evaporation technique and then they were evaluated. A microparticle formulation containing the SAN that exhibited the best entrapment efficiency and also showed a sustained release was assessed in an infect mouse model of TB. Treatment with the microparticles formulation resulted in a clereance of bacilli compared to the controls. Besides that, results suggest that these formulations do not induce any hepatotoxicity on a histopathology basis. These results demonstrated the ability to use microparticles formulations containing SAN to achieve effective results in a murine TB model and indicate the potencial of SAN as a novel antimycobacterial drug.